Alzheimer's Disease clinical trials
Showing 51–100 of 331 active trials. Describe your situation to see which ones you may be eligible for.
- Innate Immunity Stimulation Via TLR9 in Early AD
- Open-Label Extension Protocol to SNK01-AD01 Study
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
- DORA and LP in Alzheimer's Disease Biomarkers
- Open-label Extension Study in Participants With Early Alzheimer's Disease
- Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
- A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
- Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- TREAD: Time Restricted Eating Intervention for Alzheimer's Disease
- A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Vestibular Therapy in Alzheimer's Disease
- Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
- A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
- Nicotinic Acid for the Treatment of Alzheimer's Disease
- Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease
- Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
- Brain Stimulation and Cognitive Training for MCI
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
- OTC Hearing Aid and MCI
- Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Early Age-Related Hearing Loss Investigation (EARHLI)
- The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- Early-Stage Partner in Care Living Alone Plus
- Pulsed Electromagnetic Field Treatment With Dementia Patients
- Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
- Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients
- ACT for Individuals With MNCD and Their Care Partners
- Mindfulness Walking Intervention to Enhance Resilience (iWalk)
- A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- Physical Activity and Community EmPOWERment Project
- Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Impact of a Biophoton Therapy on Patients With Brain Disorders
- Neurologic Stem Cell Treatment Study
- Polyphenols and Cognitive Decline
- AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
- Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.